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Pr esen tation of C a se
Dr. Bethany L. Bartley (Pediatrics): A 22-year-old woman was seen in the pediatric 
pulmonary clinic of this hospital because of chest pain, cough, and dyspnea on 
exertion.
The patient had been well until she was 2 months of age, when an episode of 
bronchiolitis occurred. After this episode, repeated respiratory illnesses character-
ized by wheezing and cyanosis developed, and she was hospitalized frequently. The 
patient was subsequently evaluated by a pediatric pulmonologist at this hospital. 
Examination revealed decreased breath sounds at the apex of the right lung, and 
chest radiography revealed findings suggestive of congenital lobar emphysema of 
the right upper lobe. A blood test for alpha1-antitrypsin deficiency was negative. 
Transthoracic echocardiography revealed right ventricular dilatation and hypertro-
phy, mild pulmonary arterial hypertension, and a small patent ductus arteriosus. 
When the patient was 24 months of age, a right upper lobectomy, coil emboliza-
tion for the patent ductus arteriosus, and a biopsy of the right middle lobe were 
performed.
Dr. Mari Mino-Kenudson: Histopathological examination of lung specimens re-
vealed lobar emphysema of the right upper and middle lobes that was character-
ized by the presence of fewer alveoli than the number typically seen in normal 
lung tissue and hyperinflation of the existing alveoli (Fig. 1A). The number of 
bronchioles in the peripheral emphysematous areas was disproportionately low 
relative to the number of pulmonary vessels, and the central bronchi had mucus 
plugs that may have obliterated the bronchial lumens (Fig. 1B). In the hilum, the 
central bronchi had mucus plugs that resulted in partial obstruction of the bron-
chial lumens, but the amount and contour of the bronchial cartilage were normal 
(Fig. 1C). No diagnostic findings were consistent with pulmonary hypertension. 
There are two possible causes of lobar emphysema in this case: obstruction (either 
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intrinsic or extrinsic) of the developing airway, 
and overinflation of the lung as a result of con-
strictive bronchiolitis that was possibly due to 
infection. Intrinsic obstruction is often caused 
by defects in the bronchial wall, such as a defi-
ciency of bronchial cartilage or intraluminal ob-
struction by meconium, mucus plugs, or other 
substances. In this case, the bronchial cartilage 
was normal. Mucus plugs were observed at the 
time of lung resection, but they only partially 
obstructed the central airways. In addition, there 
was no evidence of constrictive bronchiolitis, 
although there were fewer bronchioles than nor-
mal in the area of the peripheral lung that was 
involved by lobar emphysema.
Dr. Bartley: The patient and her family subse-
quently moved from the United States to another 
country, and she received medical care at an-
other hospital. When she was 6 years of age, a 
spontaneous pneumothorax occurred, and evalu-
ation included genetic testing for Marfan’s syn-
drome, which was reportedly negative. During 
the next 16 years, while the patient was still 
living in another country, dyspnea on exertion 
and decreased exercise tolerance slowly devel-
oped, becoming more marked in the 12 months 
before this presentation.
Approximately 6 weeks before this presenta-
tion, intermittent chest pain developed. The pain 
was sharp, could be reproduced with palpation 
of the affected area, and was not relieved with 
the administration of ibuprofen. Episodes oc-
curred both at rest and with exertion; no precipi-
tating or exacerbating factors were identified. 
The patient was seen in the emergency depart-
ment of a local hospital, where an electrocardio-
gram was reportedly normal and a radiograph of 
the chest showed no pneumothorax. The patient 
was discharged home, and the chest pain con-
tinued to occur every few days until presentation.
On presentation to the pediatric pulmonary 
clinic of this hospital, the patient reported that 
her exercise capacity had declined during the 
past month and that she had become unable to 
climb a f light of stairs without having severe 
breathlessness. She also reported a 1-week his-
tory of productive cough; the sputum had initially 
been clear but then had become dark yellow and, 
on the day before this presentation, blood-tinged. 
The patient also had diarrhea but had no fever, 
chills, weight loss, vomiting, or abdominal pain. 
She had been born after a full-term gestation 
and had been delivered by cesarean section be-
Figure 1. Lung Specimens.
On gross examination, the biopsy specimen of the mid-
dle lobe was spongelike. On microscopic examination, 
there was no evidence of inflammation or fibrosis, but 
the number of alveoli was substantially lower than the 
number that would typically be observed in normal lung 
tissue and the existing alveoli were hyperinflated. On 
hematoxylin and eosin staining, the simplified, uniform 
enlargement of air spaces is consistent with lobar em-
physema (Panel A). A paucity of respiratory bronchioles 
in the emphysematous parenchyma is characterized by 
multiple isolated small pulmonary arteries (Panel B, 
arrows) without accompanying airways, although alve-
olar septa are normal. A section from the hilum shows 
bronchi with unremarkable immature cartilage and re-
spiratory mucosa; mucus plugs are present, but they 
only partially obstruct a few central airways (Panel C).
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cause of breech presentation; the birth weight 
was 3175 g. She had a history of depression. 
Medications included sertraline and inhaled 
albuterol as needed. She had no known allergies. 
The patient was fluent in English and Spanish 
and was an undergraduate student at a European 
university; she lived on campus during the aca-
demic year and spent the rest of the year at her 
parents’ home in the United States. She did not 
drink alcohol, smoke tobacco, or use illicit drugs. 
Her younger brother had a seizure disorder and 
developmental delays; her mother had mild joint 
hypermobility, and her father was healthy.
On examination, the temperature was 37.1°C, 
the pulse 82 beats per minute, the blood pressure 
116/72 mm Hg, the respiratory rate 18 breaths 
per minute, and the oxygen saturation 92% while 
the patient was breathing ambient air at rest. 
The height was 169 cm, the weight 47.7 kg, and the 
body-mass index (the weight in kilograms di-
vided by the square of the height in meters) 16.7. 
A blue hue was noted in the perioral region; no 
clubbing of the fingers and toes was seen. There 
was no use of accessory muscles of ventilation; 
auscultation revealed bronchial breath sounds 
in the right upper lung fields and diffuse, faint 
rhonchi during the expiratory phase. Her heart 
sounds were regular, and no murmur was noted. 
Hypermobility was present in the joints of the 
hands and arms. The remainder of the examina-
tion was normal.
Pulmonary-function testing was performed. 
The forced expiratory volume in 1 second (FEV1) 
was 23% of the predicted value, the forced vital 
capacity (FVC) was 45% of the predicted value, 
and the ratio of FEV1 to FVC was 44%. The total 
lung capacity was 108% of the predicted value, 
and the ratio of residual volume to total lung 
capacity was 65%. The diffusing capacity of the 
lung for carbon monoxide was 26% of the pre-
dicted value.
Dr. Brent P. Little: Contrast-enhanced computed 
tomography (CT) of the chest revealed hyperin-
flation of the lungs with severe confluent em-
physema and multiple apical bullae (Fig. 2A, 2B, 
and 2C); although diffuse thickening of the 
bronchial wall and areas of parenchymal air 
trapping were present, bronchiectasis was nota-
bly absent. Normal postsurgical findings includ-
ed a stump from right upper lobectomy and coil 
from embolization of a patent ductus arteriosus. 
The main pulmonary artery was enlarged, mea-
suring 3.8 cm in diameter (Fig. 2D).
Dr. Mark E. Lindsay: Transthoracic echocardiog-
raphy revealed dilatation of the right atrium, 
right ventricle, and inferior vena cava; systolic and 
diastolic flattening of the interventricular sep-
tum (see Video 1, available with the full text of 
this article at NEJM.org); and an estimated right 
ventricular systolic pressure of 65 mm Hg. The 
aortic root was not enlarged relative to the pa-
tient’s body size, and the aortic valve was tricus-
pid. However, the aortic valve was abnormally 
thickened and was prolapsed, and there was mod-
erate aortic regurgitation, which had not been 
present on echocardiograms obtained during in-
fancy. Findings suggestive of constrictive pericar-
ditis, including a septal bounce and respiratory 
variation across the mitral valve, were also seen.
Dr. Bartley: Empirical prednisone and amoxi-
cillin–clavulanic acid were prescribed, and a diag-
nostic test was performed.
Differ en ti a l Di agnosis
Dr. Ted M. Kremer: This patient is a 22-year-old 
woman with severe emphysematous obstructive 
lung disease, pulmonary hypertension, aortic 
regurgitation, and joint hypermobility. She had 
recurrent wheezing and findings of lobar em-
physema in infancy that resulted in resection 
of the right upper lobe and closure of a patent 
ductus arteriosus by means of coil embolization 
when she was 2 years of age. She had an epi-
sode of pneumothorax when she was 6 years of 
age. Her family history is notable for joint hyper-
mobility in her mother and seizures and devel-
opmental delays in a brother. Emphysematous 
obstructive lung disease is the central feature of 
this patient’s presentation, so I will construct 
my differential diagnosis around this finding. 
However, to make a unifying diagnosis in this 
case, I will also need to account for several 
other abnormalities, including congenital heart 
disease, pulmonary hypertension, and joint hyper-
mobility.
Emphysematous Obstructive Lung Disease
In patients with severe emphysematous obstruc-
tive lung disease, there is a broad differential 
diagnosis to consider. Possible causes include 
postinfectious bronchiolitis obliterans, primary 
lung diseases, childhood interstitial lung dis-
eases, immunodeficiency syndromes, autoim-
mune disorders, and connective-tissue disor-
ders, including hypermobility syndromes.
A video showing 
transthoracic 
echocardiography 
is available at 
NEJM.org
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 Postinfectious Bronchiolitis Obliterans
What can cause emphysematous lung disease 
associated with recurrent wheezing and bron-
chiolitis in infancy? Viral infection can cause 
postinfectious bronchiolitis obliterans with 
emphysematous changes similar to those of the 
Swyer–James syndrome. Infection with adeno-
virus or with other viruses, such as respiratory 
syncytial virus, is known to cause emphysema-
tous syndromes.1 Although a viral infection is a 
plausible cause of this patient’s illness and can 
be associated with chronic lung disease, it seems 
unlikely, considering the additional constella-
tion of findings in this case, including con-
genital cardiovascular disease and joint hyper-
mobility.
Figure 2. CT Scan of the Chest.
An axial image with lung windows at a level just below the carina (Panel A) shows diffuse emphysema with a panlobu-
lar appearance in both lungs (asterisks). A bronchial stump from right upper lobectomy performed for a previous 
diagnosis of congenital lobar emphysema is seen (arrow). The extensive low-attenuation regions of the lung paren-
chyma correspond to emphysema with air trapping, and smaller central areas of higher attenuation (arrowheads) 
represent less affected lung. The diameters of the pulmonary vessels in the areas of emphysema are smaller than 
those in the central areas, findings that represent vasoconstriction with vascular shunting toward more normal lung 
tissue. An axial image of the lower lungs (Panel B) shows the caudal extent of the severe emphysema. Although mild 
bronchial-wall thickening is present, bronchiectasis is notably absent. A corresponding coronal reformatted image 
(Panel C) shows the diffuse craniocaudal distribution of severe confluent emphysema. An axial image with soft-tissue 
windows (Panel D) shows a dilated main pulmonary artery, which measures 3.8 cm in diameter and is larger in diameter 
than the adjacent ascending aorta.
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Primary Lung Diseases
Primary lung diseases associated with airflow 
obstruction and emphysema are strong consid-
erations in this case. An alpha1-antitrypsin de-
ficiency was reportedly ruled out in infancy. 
Although this disorder is associated with em-
physematous lung disease, that manifestation 
usually begins in the fifth decade of life.2 This 
patient was born before routine newborn screen-
ing for cystic fibrosis, which also has manifesta-
tions of obstructive lung disease; however, cystic 
fibrosis is not typically severe in infancy, and it 
is unlikely to cause emphysematous lung changes 
at a very young age. Furthermore, other manifes-
tations of cystic fibrosis, such as malabsorption, 
would probably also be present. Primary ciliary 
dyskinesia can progress and cause obstructive 
lung disease, but this pattern of events typically 
occurs well after infancy. None of these condi-
tions are associated with congenital cardiac 
findings, but pulmonary hypertension may de-
velop later in life as a result of chronic severe 
obstructive lung disease. Joint hypermobility is 
uncommon with these conditions.
Childhood Interstitial Lung Diseases
Childhood interstitial lung diseases are associ-
ated with a variety of pulmonary findings.3 
Neuroendocrine-cell hyperplasia of infancy and 
pulmonary interstitial glycogenosis classically 
occur in infancy. They are associated with dis-
tinct findings on imaging, typical pathological 
features, and usually a more benign course than 
that seen in this patient. Surfactant dysfunction 
disorders have various outcomes. Surfactant pro-
tein B deficiency is rapidly progressive in infancy 
and usually leads to death. Surfactant protein C 
deficiency and mutation in the gene encoding 
ATP-binding cassette A3 (ABCA3) may be associ-
ated with a less severe clinical course than that 
of surfactant protein B deficiency, but both con-
ditions usually result in lifelong pulmonary man-
ifestations, such as those seen in this patient. 
However, none of these conditions are typically 
associated with congenital cardiac disease, and 
they do not provide us with a unifying diagnosis 
in this case.
Immunodeficiency Syndromes
Because this patient has obstructive lung disease 
and a history of recurring pulmonary infections, 
a diagnosis of an immunodeficiency syndrome 
is worth considering. Humoral immune respons-
es associated with antibody deficiencies increase 
the risk of sinopulmonary infections and may 
eventually cause chronic obstructive lung dis-
ease. However, this patient has not had recurrent 
or chronic sinus disease. A variety of other im-
munodeficiency syndromes could be considered, 
but the severity of this patient’s lung disease in 
infancy, together with the other findings re-
ported in infancy in this patient, make these 
syndromes unlikely.
Autoimmune Disorders
Certain autoimmune disorders can have associ-
ated pulmonary manifestations and joint hyper-
mobility. Inflammatory bowel disorders may be 
associated with bronchiectasis, bronchiolitis ob-
literans, and interstitial lung disease and may 
include joint hypermobility.4,5 These manifesta-
tions may be caused by inflammatory bowel 
disorders but may also be caused by the treat-
ment of such disorders or by infections that oc-
cur in association with that treatment. In addi-
tion, celiac disease may occur with emphysema, 
chronic bronchitis, and hypermobility. The pa-
tient had diarrhea at the time of her recent pre-
sentation, but this symptom was not described 
as persistent. However, an autoimmune disorder 
is not likely to account for her presentation in 
infancy or for congenital cardiac disease.
Connective-Tissue Disorders
The findings of aortic regurgitation, pulmonary 
hypertension, patent ductus arteriosus, emphy-
sema, pneumothorax, and joint hypermobility 
strongly suggest a connective-tissue disorder 
such as Marfan’s syndrome, the Loeys–Dietz 
syndrome, or the Ehlers–Danlos syndrome. Mar-
fan’s syndrome is an autosomal dominant con-
dition caused by mutations in the gene encoding 
fibrillin-1 (FBN1).6,7 At 6 years of age, after a 
spontaneous pneumothorax had developed, this 
patient underwent genetic testing; this gene was 
sequenced, and no mutation was identified. The 
Loeys–Dietz syndrome is an autosomal domi-
nant disorder that has some phenotypic overlap 
with Marfan’s syndrome; it is caused by disrup-
tion of genes encoding members of the canoni-
cal transforming growth factor β (TGF-β) sig-
naling cascade and has been reported to be 
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associated with aortic disease, obstructive pul-
monary disease, and pneumothorax.8 In contrast 
with Marfan’s syndrome, which is monogenic, 
the Loeys–Dietz syndrome has been associated 
with multiple gene loci, including TGFBR1 and 
TGFBR2, which encode the two subunits of the 
TGF-β receptor (TGFBR1 and TGFBR2). The 
Ehlers–Danlos syndrome is associated with mu-
tations in several different genes, with multiple 
genotypic and phenotypic variants, and most 
commonly is autosomal dominant. Type IV 
Ehlers–Danlos syndrome, also known as vascu-
lar Ehlers–Danlos syndrome, is associated with 
a defect in the gene encoding type III collagen 
(COL3A1). Vascular Ehlers–Danlos syndrome leads 
to arterial disease and may cause emphysema, 
pneumothorax, aortic disease, and patent ductus 
arteriosus.9-12 This patient’s disease in young 
adulthood has manifestations that suggest an 
Ehlers–Danlos syndrome phenotype, but the 
onset in infancy reduces the likelihood of this 
possibility.
In recent years, a disorder similar to the 
Ehlers–Danlos syndrome that is caused by muta-
tions in the gene encoding filamin A (FLNA) 
has been recognized. FLNA-related disease is an 
X-linked dominant condition that has highly 
variable phenotypic features. The most common 
manifestations include a neurologic disorder 
called periventricular heterotopia (a neuronal 
migration defect), seizure, thrombocytopenia, gas-
trointestinal dysmotility, poor growth, skeletal 
dysplasia, and hypermobility.13 Different combi-
nations of these findings may result in different 
types of FLNA-related disease; these differences 
are probably based on genetic variation. FLNA-
related disease is frequently fatal in male pa-
tients.
There is emerging recognition of a respiratory 
phenotype of this genetic disorder that occurs in 
infancy and has unique features, including car-
diovascular manifestations (aortic-valve disease 
and dilatation, patent ductus arteriosus, and pul-
monary hypertension) and pulmonary manifes-
tations (emphysema and lung cysts alternating 
with atelectasis and tracheobronchomalacia or 
stenosis).14-21 A recent review summarizes the 
cases reported in the literature to date.22 Thus 
far, at least 18 cases of FLNA-related disease with 
this respiratory phenotype have been identified 
in infancy. Most of the infants identified were 
girls, and respiratory symptoms developed at ap-
proximately 1 month of age. The outcomes were 
variable and included the use of oxygen support, 
lobectomy of severely emphysematous lobes, and 
ligation of a patent ductus arteriosus if present. 
Several patients underwent lung transplantation, 
one patient had a heart transplantation, and a 
small number of patients died from severe lung 
disease. The respiratory phenotype of FLNA- 
related disease is now considered to be a child-
hood interstitial lung disease.21 The filamin A 
protein is thought to be important in the matu-
ration of alveoli in embryologic life, a process 
that affects lung growth and development. Find-
ings similar to bronchopulmonary dysplasia due 
to alveolar simplification have been noted.19 The 
cause of FLNA mutation seems to vary and has 
been linked to deletions, missense changes, du-
plications, and nonsense variants, all of which 
may have a role in the phenotypic outcome.
This patient has a clinical picture that strong-
ly suggests an FLNA mutation characterized by 
diffuse emphysematous lung disease with severe 
airf low obstruction that began in infancy, as 
well as congenital cardiac manifestations (aortic 
disease, patent ductus arteriosus, and pulmo-
nary hypertension) and the connective-tissue 
finding of joint hypermobility. Her family his-
tory raises unique questions and is probably re-
lated to this disorder. The joint hypermobility 
that was diagnosed in her mother may provide 
evidence of an X-linked condition. At this point, 
it is unclear whether the brother’s history of 
seizures and developmental delays is associated 
with the disorder, but these conditions may be 
worth exploring. It would be unusual but possi-
ble for an FLNA mutation to occur in a young 
adult, given the description of the respiratory 
phenotype in recent years.
Dr . Ted M.  K r emer’s  Di agnosis
Mutation in the gene encoding filamin A (FLNA).
Di agnos tic Tes ting
Dr. T. Bernard Kinane: This patient initially under-
went genetic screening for a connective-tissue 
disorder when she was 6 years of age, and no 
mutations were identified. However, genetic 
panels have expanded over time, and a genetic 
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panel to test for connective-tissue disorder was 
obtained during the current evaluation.
The test results showed a heterozygous muta-
tion in FLNA: c.6830_6831delTT (p.Phe2277Ter). 
This frameshift mutation results in premature 
termination of transcription near an important 
functional domain of the filamin A protein, an 
important component of the cellular cytoskele-
ton.23 The filamin A protein links actin, which is 
essential to the regulation of cell shape and 
migration, to the cell surface. Mutations in FLNA 
result in a range of clinical syndromes.24 Gain-
of-function mutations result in skeletal dysplasia 
with hearing loss (otopalatodigital syndrome 
types I and II and the Melnick–Needles syn-
drome).25 Loss-of-function mutations in FLNA 
were first described in patients with periventricu-
lar heterotopia, which is an anomaly in which 
groups of neurons fail to migrate from the peri-
ventricular region to the cerebral cortex.26 Such 
patients usually present with seizures during the 
teenage years. Less commonly, microcephaly and 
developmental delays are seen. Since the muta-
tions were first described, features such as dila-
tation of the aorta, cardiac valvular dysplasia, 
f lexible joints, and fragile blood vessels have 
been increasingly recognized.
More recently, cases of FLNA mutation with 
pulmonary manifestations have been identified. 
The first case was identified in 2011.20 Since 
then, 17 additional case reports of lung disease 
have been described in the literature, but more 
cases are being recognized in the clinic, particu-
larly in lung transplantation centers.15-22,27 Of the 
18 patients, 15 were female, which suggests that 
males are more likely to be severely affected and 
are less likely to survive to birth. All but 1 of 
these patients were born at full term. All had 
periventricular heterotopia. The onset of lung 
disease occurred during the first 3 months of 
life in all 18 patients. In 17 patients, CT scans 
showed areas with lung hyperinflation, a find-
ing that was also seen in this case. In many of 
the patients, whole lobes were hyperinflated and 
lobar emphysema was noted. In total, 10 of the 
patients had a patent ductus arteriosus, and 4 had 
pulmonary hypertension. A total of 8 patients 
died or had lung transplantation. Most of these 
patients had mutations that occurred near im-
portant functional domains of the molecule, 
such as the actin-binding domain and the do-
main that is important for dimerization of these 
molecules. In this case, the mutation occurred 
near an area that is important for both integrin 
binding and dimerization. In the case reports, 
13 patients had a duplication or deletion with a 
resulting frameshift mutation, 1 had a nonsense 
mutation, and 4 had a missense mutation. There 
was no apparent association between mutation 
type and outcome, but the number of cases is 
small. Overall, this patient had a typical pulmo-
nary presentation and phenotype for a patient 
with an FLNA mutation.
Gene tic Scr eening
Ms. Megan H. Hawley: For patients with FLNA mu-
tations, screening recommendations would gen-
erally include a baseline neurologic evaluation, 
referral to an epilepsy specialist if seizures oc-
cur, and cardiovascular imaging studies, such as 
magnetic resonance angiography to assess the 
risk of stroke and echocardiography to investi-
gate whether congenital cardiac anomalies or 
aortopathy are present.28 To date, there are no 
specific recommendations for pulmonary assess-
ment. However, an initial pulmonary evaluation 
could be considered for affected relatives when 
pulmonary disease is present in the proband.
None of the patient’s family members had 
clinical features diagnostic of periventricular 
heterotopia; however, her family history sug-
gested that the variant may have been mater-
nally inherited. The patient’s mother reported a 
history of recurrent bronchitis, hypertensive cri-
sis, edema, and mild joint hypermobility. The 
patient’s maternal grandmother was reported 
to have joint pain and asthma and had several 
siblings who had died early in infancy. The 
exact cause of death and the sex of these chil-
dren were unknown. Although the maternal fam-
ily history was somewhat suggestive of this dis-
order, the patient’s mother tested negative for 
the c.6830_6831delTT (p.Phe2277Ter) FLNA var-
iant. Because it is unlikely that the patient’s 
father carries the variant, given that affected 
males are likely to have a severe phenotype, one 
can conclude that the variant most likely oc-
curred as a new mutation in the patient that 
was not inherited from either parent, which is 
not uncommon for disease-causing mutations 
in FLNA.29
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Each female offspring of the patient would 
have a 50% chance of inheriting the mutation, 
although the expected clinical presentation of 
those offspring is difficult to predict. Because 
the majority of loss-of-function variants in FLNA 
lead to perinatal death in male offspring, preg-
nancies with affected male offspring would 
most likely result in spontaneous abortion. The 
possibility of live birth of a severely affected 
male child is low but has been reported.13
Dr. Virginia M. Pierce (Pathology): Dr. Kinane, 
would you tell us what happened with this pa-
tient?
Dr. Kinane: When we evaluated this patient, 
she had worsening pulmonary hypertension, 
with an estimated right ventricular systolic pres-
sure of 65 mm Hg. She went back to her parents’ 
home with a plan for urgent cardiology consul-
tation. Since her evaluation at this hospital, she 
has been treated with oxygen and nitric oxide 
and subsequently has begun receiving treatment 
with sildenafil and bosentan. She is now also 
receiving supplemental oxygen at night.
Fina l Di agnosis
Interstitial lung disease associated with FLNA 
mutation.
This case was presented at Pediatric Grand Rounds.
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